Company: UPC
Filing Date: 2025-09-03
Form Type: 6-K
Source: 0001213900-25-084040
Chunk: 3

Company: Universe Pharmaceuticals INC
Filing Date: 2025-09-03
Form: 6-K
Chunk 3
---
itation and vote of proxies if, at the time of the Meeting, there are not sufficient votes for, 
 or otherwise in connection with, the approval of the foregoing proposals.” (“Proposal Eight”)                                             |

| Resolution                  |     | For |        |   |     | Against |       |   |     | Abstain |    |
| Proposal Eight              |     |     | 11,140 |   |     |         | 3,180 |   |     |         | 32 |
| Percentage of Voted Shares: |     |     |  77.79 | % |     |         | 22.21 | % |     |         |    |

<div align='center'>3

SIGNATURES</div>

Pursuant to the requirements
of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.

| Date: September 3, 2025 | Universe Pharmaceuticals INC. 
 By:                           | /s/ Gang Lai            |
|:------------------------|:------------------------------|:------------------------|
|                         |                               | Gang Lai                |
|                         |                               | Chief Executive Officer |

<div align='center'>4</div>